Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test MRD For B- ALL Test By Flowcytometry is 7 days.

What are the prerequisites for the test MRD For B- ALL Test By Flowcytometry

  • Peripheral Blood or Bone Marrow sample
  • Diagnosis of B-cell Acute Lymphoblastic Leukemia (B-ALL)
  • Previous treatment with chemotherapy
  • Results from previous flow cytometry tests
  • Consent from the patient or legal guardian

What are the measure values for the test MRD For B- ALL Test By Flowcytometry

Test MRD For B-ALL Test By Flowcytometry Measure Values
Positive Result >0.01% of total nucleated cells
Indeterminate Result 0.01% - 0.1% of total nucleated cells
Negative Result <0.01% of total nucleated cells

What does this test MRD For B- ALL Test By Flowcytometry identify?

This test, MRD for B-ALL Test by Flowcytometry, identifies minimal residual disease (MRD) in patients with B-cell acute lymphoblastic leukemia (B-ALL) using flow cytometry. MRD refers to the small number of cancer cells that may remain in the body during or after treatment. Monitoring MRD levels helps in assessing the effectiveness of treatment and predicting the likelihood of disease recurrence.

Why is this test MRD For B- ALL Test By Flowcytometry taken?

MRD For B- ALL Test By Flowcytometry

Reasons for Taking the Test

Minimal Residual Disease (MRD) testing is crucial for patients with B-cell acute lymphoblastic leukemia (B-ALL) as it helps in determining the effectiveness of treatment and predicting the risk of relapse. Flow cytometry is a technique used to detect and quantify MRD in the bone marrow or blood samples of B-ALL patients.

Some of the reasons for taking the MRD test by flow cytometry include:

  1. Evaluating the response to treatment: MRD testing can assess the response of the patient to chemotherapy or other treatments. A decreasing MRD level indicates a good response, while a stable or increasing MRD level may suggest the need for further intervention.
  2. Predicting relapse: Monitoring MRD levels over time can help in predicting the risk of relapse. Patients with higher MRD levels are more likely to experience disease recurrence, while those with undetectable MRD have a lower risk of relapse.
  3. Guiding treatment decisions: MRD results can guide healthcare providers in making decisions about the intensity and duration of treatment. Patients with persistent MRD may require additional therapy or a change in treatment regimen.
  4. Assessing overall prognosis: MRD testing provides valuable information about the prognosis of B-ALL patients. Those with undetectable MRD have a better prognosis and are more likely to achieve long-term remission.

Overall, MRD testing by flow cytometry is essential for optimizing treatment strategies, monitoring disease progression, and improving outcomes for patients with B-ALL.

No FAQs available.

Customer Google Rating